- Home
- / Empress Therapeutics
Empress Therapeutics
Total Funding
$50 M
Empress Therapeutics Summary
Company Summary
- Overview
- Empress Therapeutics is a company that develops technology for drug discovery. It offers Chemilogics, a platform that uses patient data, DNA, AI, and synthetic biology to develop drugs for cancer, neurodegenerative, and infectious diseases.
- Type
- Private
- Status
- Active
- Founded
- 2020
- HQ
- Cambridge, MA, US | view all locations
- Website
- https://www.empresstx.com
- Cybersecurity rating
Table of Contents
Key People
Murray McKinnon, Chief Scientific Officer
Sabrina Yang, Co-Founder & Chief Innovation Officer
Dawn Thompson, Senior Vice President, Head of Platform Development
LocationsView all
1 location detected
Cambridge, MA HQ
United States
790 Memorial Drive, Suite 2B